Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Non-Malignant Channel:
Paroxysmal Nocturnal Hemoglobinuria

Explore the latest updates and expert interviews

Welcome to The Paroxysmal Nocturnal Hemoglobinuria (PNH) Channel

VJHemOnc brings you the latest advances in PNH directly from leading experts. Explore The PNH Channel and stay up to date with the latest developments with our exclusive video interviews, as well as informative podcasts and roundtable discussions.

The PNH Channel covers recent advances in the field, including novel therapies being explored, ongoing clinical trials, and more.

Treating Patients with PNH and AA 1:29
Treating Patients with PNH and AA
Anita Hill • 13 Jun 2019
PNH treatment: ravulizumab vs. eculizumab 1:40
PNH treatment: ravulizumab vs. eculizumab
Anita Hill • 13 Jun 2019
International PNH Registry: studies, activity & eculizumab efficacy 2:30
International PNH Registry: studies, activity & eculizumab efficacy
Talha Munir • 1 Apr 2019
A potential new treatment for PNH: C3 inhibitor APL-2 reduces markers of hemolysis 4:25
A potential new treatment for PNH: C3 inhibitor APL-2 reduces markers of hemolysis
Raymond Wong • 2 Apr 2019
Transplantation for PNH? 0:48
Transplantation for PNH?
Regis Peffault de Latour • 18 Mar 2018
Thrombosis: a lethal complication in PNH 1:41
Thrombosis: a lethal complication in PNH
Anita Hill • 16 Apr 2018
Diagnostic markers to catch thrombosis early in PNH 0:42
Diagnostic markers to catch thrombosis early in PNH
Anita Hill • 16 Apr 2018
Future advancements in the treatment of PNH 1:12
Future advancements in the treatment of PNH
Peter Hillmen • 22 Jun 2017

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals